Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-19-003387
Date:2019-06-04
Issuer: ARRAY BIOPHARMA INC (ARRY)
Original Submission Date:

Reporting Person:

SANDOR VICTOR
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET BOULDER, CO 80301

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-06-04 M 100,000 a $7.30 309,543 direct
COMMON STOCK 2019-06-04 S 100,000 d $28.51 209,543 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 7.3 2019-06-04 deemed execution date M 100,000 (d) 2025-04-01 common stock 100,000 $7.30 87,500 direct
Footnotes
IDfootnote
f1 these trades were made pursuant to a rule 10b5-1 trading plan.
f2 the price reported for these shares is the weighted average sale price of transactions made at prices from $28.50 to $28.59. details of actual prices for shares sold are available from the issuer upon request.
f3 the option vests in four equal annual installments beginning on april 1, 2016.
WhaleWisdom Logo

Elevate your investments